ESR1 and cancer: Based on our observations, one could hypothesize that among ER/PgR-negative or TNBC tumors, subsets of less aggressive cancers with better prognosis may be identified, according to their angiogenic profile and suggest that more than one of the components of the VEGF signaling pathway rather than an individual member may affect prognosis of breast cancer patients.